Clinical Safety Management in Pharma: How to Manage Risk Across the Drug Development Lifecycle
Clinical trial safety management is essential across the drug development lifecycle. From first-in-human studies to late-phase development and post-marketing commitments, companies need a clear system for identifying, assessing, documenting, and acting on safety...
Global Case Processing in Pharmacovigilance: Practical Guide to Compliance, Quality, and Scale
What happens to pharmacovigilance case processing services with multi-market expansion? As operations increase, what once worked in a single-country setup becomes difficult to manage throughout regions. For many marketing authorization holders (MAHs), the challenge...
Case Study: International & Local Pharmacovigilance/Medical Information Services – Urgent Action
In this case study, we share how Biomapas successfully supported a pharmaceutical company during a critical vendor change, delivering a seamless transition without disruption of Pharmacovigilance (PV) and Medical Information (MI) services. Faced with a non-negotiable...
Marketing Pharmaceutical Products in CIS/Eurasian Economic Union
The interest of pharmaceutical companies in expanding business across the Commonwealth of Independent States (CIS) and the Eurasian Economic Union (EAEU) has been constantly growing. For the same reason, Biomapas provides end-to-end regulatory support in these...
